Literature DB >> 21075290

Lower gastrointestinal tract cancer predisposition syndromes.

Neel B Shah1, Noralane M Lindor.   

Abstract

Although inherited predisposition to colorectal cancer (CRC) has been suspected for more than 100 years, definitive proof of Mendelian syndromes had to await maturation of molecular genetic technologies. Since the l980s, the genetics of several clinically distinct entities has been revealed. Five disorders that share a hereditary predisposition to CRC are reviewed in this article.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21075290      PMCID: PMC4103645          DOI: 10.1016/j.hoc.2010.08.012

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  174 in total

Review 1.  Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.

Authors:  M H Nieuwenhuis; H F A Vasen
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-24       Impact factor: 6.312

2.  Significance of endometrial cells in the detection of endometrial carcinoma and its precursors.

Authors:  A B Ng; J W Reagan; S Hawliczek; B W Wentz
Journal:  Acta Cytol       Date:  1974 Sep-Oct       Impact factor: 2.319

3.  The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.

Authors:  J M Cunningham; C Y Kim; E R Christensen; D J Tester; Y Parc; L J Burgart; K C Halling; S K McDonnell; D J Schaid; C Walsh Vockley; V Kubly; H Nelson; V V Michels; S N Thibodeau
Journal:  Am J Hum Genet       Date:  2001-08-24       Impact factor: 11.025

Review 4.  Familial adenomatous polyposis.

Authors:  Polymnia Galiatsatos; William D Foulkes
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

5.  Mortality in patients with familial adenomatous polyposis.

Authors:  M L Arvanitis; D G Jagelman; V W Fazio; I C Lavery; E McGannon
Journal:  Dis Colon Rectum       Date:  1990-08       Impact factor: 4.585

6.  Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma.

Authors:  S Olschwang; C Boisson; G Thomas
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

7.  MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.

Authors:  Françoise Charbonnier; Sylviane Olschwang; Qing Wang; Cécile Boisson; Cosette Martin; Marie-Pierre Buisine; Alain Puisieux; Thierry Frebourg
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

8.  Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.

Authors:  Natalie Jones; Stefanie Vogt; Maartje Nielsen; Daria Christian; Petra A Wark; Diana Eccles; Emma Edwards; D Gareth Evans; Eamonn R Maher; Hans F Vasen; Frederik J Hes; Stefan Aretz; Julian R Sampson
Journal:  Gastroenterology       Date:  2009-04-23       Impact factor: 22.682

9.  Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma.

Authors:  K Okamoto; S Toyokuni; K Uchida; O Ogawa; J Takenewa; Y Kakehi; H Kinoshita; Y Hattori-Nakakuki; H Hiai; O Yoshida
Journal:  Int J Cancer       Date:  1994-09-15       Impact factor: 7.396

10.  Germline susceptibility to colorectal cancer due to base-excision repair gene defects.

Authors:  Susan M Farrington; Albert Tenesa; Rebecca Barnetson; Alice Wiltshire; James Prendergast; Mary Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  Am J Hum Genet       Date:  2005-05-03       Impact factor: 11.025

View more
  2 in total

1.  Identification of patients at risk for hereditary colorectal cancer.

Authors:  Nitin Mishra; Jason Hall
Journal:  Clin Colon Rectal Surg       Date:  2012-06

Review 2.  Microsatellite instability in colorectal cancer.

Authors:  Jafar Nouri Nojadeh; Shahin Behrouz Sharif; Ebrahim Sakhinia
Journal:  EXCLI J       Date:  2018-01-22       Impact factor: 4.068

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.